Association study between the phenotype migraine without aura - Panic disorder and dopaminergic receptor genes

Pharmacological Research

Volumn 48, Issue 5, 2003, Pages 531-534

  Stochino, Maria Erminia ^a   Asuni, Carlo ^a   Congiu, Donatella ^a   Del Zompo, Maria ^a   Severino, Giovanni ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Dopamine receptor genes; Migraine; Panic disorder

Indexed keywords

DOPAMINE RECEPTOR;

ARTICLE; CHROMOSOME; DOPAMINERGIC SYSTEM; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; NEUROCHEMISTRY; PANIC; PHENOTYPE; PRIORITY JOURNAL;

EID: 0041326483     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00213-5     Document Type: Article

References (30)

1. Stewart W., Breslau N., Keck P.E. Comorbidity of migraine and panic disorder. Neurology. 44(Suppl 7):1994;S23-S27.
2. Ossipova V.V., Kolosova O.A., Vein A.M. Migraine associated with panic attacks. Cephalalgia. 19:1999;728-731.
3. Russell M.B., Hilden J., Sorensen S.A., Olesen J. Familial occurrence of migraine without aura and migraine with aura. Neurology. 43:1993;1369-1373.
4. Russell M.B., Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 311:1995;1227.
5. Montagna P. Molecular genetics of migraine headaches: a review. Cephalalgia. 20:2000;3-14.
6. Van der Heuvel O.A., Van de Wetering B.J., Veltmah D.J., Pauls D.L. Genetic studies of panic disorder: a review. J. Clin. Psychiatry. 61:2000;756-766.
7. Del Zompo M., Cherchi A., Palmas M.A., Ponti M., Bocchetta A., Gessa G.L.et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology. 51:1998;781-786.
8. Headache Classification Committee of the International Headache Society: classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pains. Cephalalgia 1998: 8(Suppl 7): 1-96.
9. American Psychiatric Association. DSM-IV: diagnostic and statistical manual for mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
10. Lahiri D.K., Nurnberger J.I. Jr. A rapid non-enzymatic method for preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res. 19:1991;44-54.
11. Cichon S., Nothen M., Erdmann J., Propping P. Detection of four polymorphic sites in the human dopamine D1 receptor gene (DRD1). Hum. Mol. Genet. 3:1994;209.
12. Sarkar G., Kapelner S., Grandy D.K., Marchionni M., Civelli O., Sobel J.et al. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics. 11:1991;8-14.
13. Hauge X.Y., Crandy D.K., Eubank J.H., Evans G.A., Civelli O., Litt M. Detection and characterization of additional DNA polymorphisms in the D2 receptor gene. Genomics. 10:1991;527-530.
14. Lannfelt L., Sokoloff P., Martres M.P., Pilon C., Giros B., Jonsson E.et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr. Genet. 2:1992;249-256.
15. Sherrington R., Mankoo B., Attwood J., Kalsi G., Curtis D., Buetow K.et al. Cloning of the human dopamine D5 receptor gene and identification of highly polymorphic microsatellite for DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P. Genomics. 18:1993;423-425.
16. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
17. Sham P.C., Curtis D. An extended Transmission Disequilibrium test (TDT) for multiallele marker loci. Ann. Hum. Genet. 59:1995;323-336.
18. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59:1995;97-105.
19. Breslau N., Davis G.C. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J. Psychiatr. Res. 27:1993;211-221.
20. Breslau N., Schultz L.R., Stewart W.F., Lipton R., Welch K.M. Headache types and panic disorder: directionality and specificity. Neurology. 56:2001;350-354.
21. Pitchor W., Ansscau M., Moreno A.G., Hansenne M., Von Frenckell R. Dopaminergic function in panic disorder: comparison with major and minor depression. Biol. Psychiatry. 32:1992;1004-1011.
22. Anthony J.C., Tien A.Y., Petronis K.R. Epidemiologic evidence on cocaine use and panic attacks. Am. J. Epidemiol. 129:1989;543-549.
23. Woo J.M., Yoon K.S., Yu B.H. Catechol-O-methyltransfearse genetic polymorphism in panic disorder. Am. J. Psychiatry. 159:2002;1785-1787.
24. Crawford F., Hoyne J., Diaz P., Osborne A., Dorotheo J., Sheetan D.et al. Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorder. Am. J. Med. Genet. 60:1995;322-334.
25. Cichon S., Nothen M.M., Catalano M., Di Bella D., Maier W., Lichtermann D.et al. Identification of two novel polymorphisms and a rare deletion variant in the human dopamine D4 receptor gene. Psychiatr Genet. 5:1995;97-103.
26. Hamilton S.P., Haghighi F., Heiman G.A., Klein D.F., Hodge S.E., Fryer A.J.et al. Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. Am. J. Med. Genet (Neuropsychiatric Genet). 96:2000;324-330.
27. Peroutka S.J. Dopamine and migraine. Neurology. 49:1997;1-6.
28. Peroutka S.J., Wilholt T., Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology. 49:1997;201-206.
29. Mascia A., Mra J., Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological and therapeutic data. Cephalalgia. 18:1998;174-182.
30. Cavalli-Sforza L.L., Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur. J. Hum. Genet. 1:1993;3-18.